Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
Diana F. Lázaro, Maria Angeliki S. Pavlou, Tiago F. Outeiro
Experimental Neurology (2017) Vol. 298, pp. 162-171
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

In vitro Models of Neurodegenerative Diseases
Anna Slanzi, Giulia Iannoto, Barbara Rossi, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 212
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
Iosif Pediaditakis, Konstantia Kodella, Dimitris V. Manatakis, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 162
Advances in Parkinson’s Disease: 200 Years Later
Natalia López‐González del Rey, Ana Quiroga‐Varela, Elisa Garbayo, et al.
Frontiers in Neuroanatomy (2018) Vol. 12
Open Access | Times Cited: 130
Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
Hayate Javed, Mohamed Fizur Nagoor Meeran, Sheikh Azimullah, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 101
Cellular models of alpha‐synuclein toxicity and aggregation
Marion Delenclos, Jeremy D. Burgess, Agaristi Lamprokostopoulou, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 566-576
Open Access | Times Cited: 99
Synucleinopathies: Where we are and where we need to go
Inês Caldeira Brás, Antonio Dominguez‐Meijide, Ellen Gerhardt, et al.
Journal of Neurochemistry (2020) Vol. 153, Iss. 4, pp. 433-454
Open Access | Times Cited: 82
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
Yumin Wang, Luyan Gao, Jichao Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 75
New Promising Therapeutic Avenues of Curcumin in Brain Diseases
Tarek Benameur, Giulia Giacomucci, Maria Antonietta Panaro, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 236-236
Open Access | Times Cited: 74
Cell models for Alzheimer’s and Parkinson’s disease: At the interface of biology and drug discovery
Sandra Cetin, Damijan Knez, Stanislav Gobec, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112924-112924
Open Access | Times Cited: 42
Curcumin, inflammation, and neurological disorders: How are they linked?
Prachi Garodia, Mangala Hegde, Ajaikumar B. Kunnumakkara, et al.
Integrative Medicine Research (2023) Vol. 12, Iss. 3, pp. 100968-100968
Open Access | Times Cited: 37
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease
Samuel Peña‐Díaz, Javier García‐Pardo, Salvador Ventura
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 839-839
Open Access | Times Cited: 27
Experimental models of Parkinson’s disease: Challenges and Opportunities
Roshan Lal, Aditi Singh, S. Watts, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176819-176819
Closed Access | Times Cited: 11
Binding of α-synuclein oligomers to Cx32 facilitates protein uptake and transfer in neurons and oligodendrocytes
Juan F. Reyes, Christopher Sackmann, Alana Hoffmann, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 1, pp. 23-47
Open Access | Times Cited: 58
Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition
Azad Farzadfard, Annekatrin König, Steen V. Petersen, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 5, pp. 101848-101848
Open Access | Times Cited: 34
Anti-Aging and Neuroprotective Properties of Grifola frondosa and Hericium erinaceus Extracts
Farida Tripodi, Ermelinda Falletta, Manuela Leri, et al.
Nutrients (2022) Vol. 14, Iss. 20, pp. 4368-4368
Open Access | Times Cited: 31
Research Models to Study Ferroptosis’s Impact in Neurodegenerative Diseases
Inês Costa, Daniel José Barbosa, Vera Silva, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1369-1369
Open Access | Times Cited: 20
Exploring Influence of Production Area and Harvest Time on Specialized Metabolite Content of Glycyrrhiza glabra Leaves and Evaluation of Antioxidant and Anti-Aging Properties
Teresa Docimo, Rita Celano, Alessia Lambiase, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 93-93
Open Access | Times Cited: 7
The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling
Tourandokht Baluchnejadmojarad, Seyed-Mohammad Eftekhari, Nida Jamali-Raeufy, et al.
Experimental Gerontology (2017) Vol. 100, pp. 70-76
Closed Access | Times Cited: 54
Oxidative stress and aging: Learning from yeast lessons
Elis C. A. Eleuthério, Aline de Araújo Brasil, Mauro Braga França, et al.
Fungal Biology (2017) Vol. 122, Iss. 6, pp. 514-525
Closed Access | Times Cited: 52
Neuroprotective effect of chlorogenic acid on Parkinson's disease like symptoms through boosting the autophagy in zebrafish
Xin Gao, Baoyue Zhang, Yuanteng Zheng, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175950-175950
Closed Access | Times Cited: 16
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway
Marina I. Oliveira da Silva, Miguel Santejo, Isaac W. Babcock, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 5
Quantitative Characterization of α-Synuclein Aggregation in Living Cells through Automated Microfluidics Feedback Control
Giansimone Perrino, Cathal Wilson, Marco Santorelli, et al.
Cell Reports (2019) Vol. 27, Iss. 3, pp. 916-927.e5
Open Access | Times Cited: 40
Combined Treatment with Three Natural Antioxidants Enhances Neuroprotection in a SH-SY5Y 3D Culture Model
Pasquale Marrazzo, Cristina Angeloni, Silvana Hrelia
Antioxidants (2019) Vol. 8, Iss. 10, pp. 420-420
Open Access | Times Cited: 37
Classic and evolving animal models in Parkinson's disease
Tanvi Pingale, Girdhari Lal Gupta
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173060-173060
Closed Access | Times Cited: 35
Surface Area of Graphene Governs Its Neurotoxicity
Şeyma Taşdemir, Zehra Gül Morçimen, Aslı Aybike Doğan, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 6, pp. 3297-3305
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top